Frank Pietrantonio, Alex Serreqi, Horst Zerbe, Per Svenningsson, & Ludwig Aigner. (2024). The leukotriene receptor antagonist montelukast as a potential therapeutic adjuvant in multiple sclerosis - a review. Frontiers Media S.A..
Chicago Style (17th ed.) CitationFrank Pietrantonio, Alex Serreqi, Horst Zerbe, Per Svenningsson, and Ludwig Aigner. The Leukotriene Receptor Antagonist Montelukast as a Potential Therapeutic Adjuvant in Multiple Sclerosis - a Review. Frontiers Media S.A., 2024.
MLA (9th ed.) CitationFrank Pietrantonio, et al. The Leukotriene Receptor Antagonist Montelukast as a Potential Therapeutic Adjuvant in Multiple Sclerosis - a Review. Frontiers Media S.A., 2024.
Warning: These citations may not always be 100% accurate.